<html>
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
   
      <title>Anthelmintic drugs
         		
      </title>
      <meta name="generator" content="DocBook XSL Stylesheets V1.67.2">
      <link rel="start" href="#anthelmin_ArticleID" title="Anthelmintic drugs&#xA;">
      <link rel="next" href="#sec1" title="1.&nbsp;Introduction to anthelmintics">
      <!--#include virtual="/ssi/header_article.html" -->
   </head>
   <body bgcolor="white" text="black" link="#0000FF" vlink="#840084" alink="#0000FF">
<!--#include virtual="/ssi/boilerplate.html" -->
   	<div class="html_to_pdf_link">
		<a href="anthelminticdrugs.pdf">Download PDF version</a>
	</div>
      <div class="article" lang="en">
         <div class="titlepage">
            <div>
               <div>
                  <h1 class="title"><a name="anthelmin_ArticleID"></a>Anthelmintic drugs<sup><a name="d0e8" href="#ftn.d0e8">*</a></sup>
                     		
                  </h1>
               </div>
               <div>
                  <div class="author"><span class="author"><span class="othername">Lindy Holden-Dye<em><span class="remark"><sup><a name="d0e30" href="#ftn.d0e30">&sect;</a></sup></span></em> and Robert J. Walker</span><br></span><span class="affiliation"><span class="address">School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton SO16 7PX, UK
                           <p></p></span></span></div>
               </div>
            </div>
            <hr>
         </div>
         <div class="toc">
         
                 <div id="section_locator"><a href="/toc_diseasemoddrugdiscov.html">
	         <b>This chapter is in WormBook section:</b><br />
		       > Disease models and drug discovery
		</a></div><hr />
		
<a href="http://www.wormbase.org/forums/index.php?board=315.0" title="Discuss WormBook" target="_blank"><font color="#9932cc"><b>View/Add Comments</b></font></a><br/>
<IFRAME  SRC="http://tazendra.caltech.edu/~acedb/cgi-bin/wormbook_comment.cgi?name=Anthelmintic+drugs" HEIGHT=50 WIDTH=180 FRAMEBORDER=0 SCROLLING=NO allowTransparency="true"></IFRAME>

<hr />
            <p><b>Table of Contents</b></p>
            <dl>
               <dt><span class="sect1"><a href="#sec1">1. Introduction to anthelmintics</a></span></dt>
               <dt><span class="sect1"><a href="#sec2">2. Is <span class="emphasis"><em>C. elegans</em></span> a model &#8216;parasite&#8217;?</a></span></dt>
               <dt><span class="sect1"><a href="#sec3">3. Approaches for the study of anthelmintics in <span class="emphasis"><em>C. elegans</em></span></a></span></dt>
               <dt><span class="sect1"><a href="#sec4">4. Classes of anthelmintic drugs</a></span></dt>
               <dd>
                  <dl>
                     <dt><span class="sect2"><a href="#sec4_1">4.1. Piperazine</a></span></dt>
                     <dt><span class="sect2"><a href="#sec4_2">4.2. Benzimidazoles</a></span></dt>
                     <dt><span class="sect2"><a href="#sec4_3">4.3. Levamisole, pyrantel and morantel</a></span></dt>
                     <dt><span class="sect2"><a href="#sec4_4">4.4. Paraherquamide</a></span></dt>
                     <dt><span class="sect2"><a href="#sec4_5">4.5. Ivermectin (macrocylic lactones and milbemycins)</a></span></dt>
                     <dt><span class="sect2"><a href="#sec4_6">4.6. Emodepside (cyclodepsipeptides, PF1022A)</a></span></dt>
                     <dt><span class="sect2"><a href="#sec4_7">4.7. Nitazoxanide</a></span></dt>
                  </dl>
               </dd>
               <dt><span class="sect1"><a href="#sec5">5. The future</a></span></dt>
               <dt><span class="sect1"><a href="#d0e1307">6. References</a></span></dt>
            </dl>
         </div>
         <div class="abstract">
            <p class="title"><span class="bold"><strong>Abstract</strong></span></p>
            <p><span class="emphasis"><em><span class="bold"><strong>C. elegans</strong></span></em></span> <span class="bold"><strong>is sensitive to the majority of anthelmintic drugs that are used against parasitic worm infections of humans and livestock.
                     This has provided the opportunity to use molecular genetic techniques in the worm for mode of action studies. These approaches
                     continue to be of considerable value to the field of parasitology. In addition, there are numerous examples of anthelmintic
                     drugs providing exceptionally useful pharmacological tools to delineate fundamental aspects of cell signalling in</strong></span> <span class="emphasis"><em><span class="bold"><strong>C. elegans.</strong></span></em></span> <span class="bold"><strong>This has primarily been achieved through the use of anthelmintics in forward genetic screens followed by the mapping and characterization
                     of genes that confer altered susceptibility to the drug. Less fruitful so far, but nonetheless useful, has been the direct
                     use of</strong></span> <span class="emphasis"><em><span class="bold"><strong>C. elegans</strong></span></em></span> <span class="bold"><strong>for anthelmintic discovery programmes. In this brief review we provide an introduction to the use of</strong></span> <span class="emphasis"><em><span class="bold"><strong>C. elegans</strong></span></em></span> <span class="bold"><strong>as a &#8216;model parasite&#8217;, outline the actions of the main classes of anthelmintics, and highlight approaches that have been of
                     particular value.</strong></span></p>
         </div>
         <div class="sect1" lang="en">
            <div class="titlepage">
               <div>
                  <div>
                     <h2 class="title" style="clear: both"><a name="sec1"></a>1.&nbsp;Introduction to anthelmintics
                     </h2>
                  </div>
               </div>
            </div>
            <p>Anthelmintics are drugs that are used to treat infections with parasitic worms. This includes both flat worms, e.g., flukes
               and tapeworms and round worms, i.e., nematodes. They are of huge importance for human tropical medicine and for veterinary
               medicine. The World Health Organization estimates that a staggering 2 billion people harbour parasitic worm infections (<a href="http://www.who.int/wormcontrol/statistics/" target="_blank">http://www.who.int/wormcontrol/statistics/</a>). Parasitic worms also infect livestock and crops, affecting food production with a resultant economic impact. Also of importance
               is the infection of domestic pets. Indeed, the companion animal market is a major economic consideration for animal health
               companies undertaking drug discovery programmes.
            </p>
            <p>Despite the prevalence of parasitic worms, anthelmintic drug discovery is the poor relation of the pharmaceutical industry.
               The simple reason is that the nations which suffer most from these tropical diseases have little money to invest in drug discovery
               or therapy. It comes as no surprise therefore that the drugs available for human treatment were first developed as veterinary
               medicines. There is thus a pitifully small repertoire of chemotherapeutic agents available for treatment (see <a href="#table1" title="Table 1. Key drugs registered for the treatment of parasitic worms in humans.">Table 1</a>). In some respects, this situation has been exacerbated by the remarkable success of ivermectin over the last twenty years
               (<a href="#bib22">Geary, 2005</a>), which has decreased motivation for anthelmintic drug discovery programmes (<a href="#bib23">Geary, Sangster and Thompson, 1999</a>). This prompts concern, as anthelmintic resistance has been widely reported in livestock and it may also only be a matter
               of time before this phenomenon occurs in parasites of humans.
            </p>
            <div class="table"><a name="table1"></a><p class="title"><span class="bold"><strong>Table 1. Key drugs registered for the treatment of parasitic worms in humans.</strong></span></p>
               <table summary="Table 1. Key drugs registered for the treatment of parasitic worms in humans." border="1">
                  <colgroup>
                     <col align="left">
                     <col align="left">
                  </colgroup>
                  <tbody>
                     <tr>
                        <td align="left"><span class="bold"><strong>Schistosomiasis (blood fluke)</strong></span></td>
                        <td align="left"><span class="bold"><strong>Intestinal round worms</strong></span></td>
                     </tr>
                     <tr>
                        <td align="left">Antimonials</td>
                        <td align="left">Piperazine</td>
                     </tr>
                     <tr>
                        <td align="left">Metrifonate</td>
                        <td align="left">Benzimidazoles</td>
                     </tr>
                     <tr>
                        <td align="left">Oxamnaquine</td>
                        <td align="left">Morantel</td>
                     </tr>
                     <tr>
                        <td align="left">Praziquantel</td>
                        <td align="left">Pyrantel</td>
                     </tr>
                     <tr>
                        <td align="left">&nbsp;</td>
                        <td align="left">Levamisole</td>
                     </tr>
                     <tr>
                        <td align="left"><span class="bold"><strong>Cestodiasis (tape worm)</strong></span></td>
                        <td align="left">Avermectins and milbemycins</td>
                     </tr>
                     <tr>
                        <td align="left">Niclosamide</td>
                        <td align="left">Closantel (and halogenated salicylamides)</td>
                     </tr>
                     <tr>
                        <td align="left">Benzimidazoles</td>
                        <td align="left">Emodepside</td>
                     </tr>
                     <tr>
                        <td align="left">Praziquantel</td>
                        <td align="left">&nbsp;</td>
                     </tr>
                     <tr>
                        <td align="left"><span class="bold"><strong>Fasciolasis (liver fluke)</strong></span></td>
                        <td align="left"><span class="bold"><strong>Filariasis (tissue round worms)</strong></span></td>
                     </tr>
                     <tr>
                        <td align="left">Praziquantel</td>
                        <td align="left">Diethylcarbmazine</td>
                     </tr>
                     <tr>
                        <td align="left">Closantel</td>
                        <td align="left">Suramin</td>
                     </tr>
                     <tr>
                        <td align="left">(and halogenated salicylamides)</td>
                        <td align="left">Ivermectin</td>
                     </tr>
                  </tbody>
               </table>
            </div>
            <p>Broad spectrum anthelmintics are effective against parasitic flat worms and nematodes. However, the majority of drugs are
               more limited in their action, e.g., praziquantel, a drug used in the treatment of schistosomiasis and thought to act by disrupting
               calcium homeostasis (<a href="#bib27">Greenberg, 2005</a>), has no activity against nematodes (see <a href="#table1" title="Table 1. Key drugs registered for the treatment of parasitic worms in humans.">Table 1</a>). For the purpose of this review we will focus on drugs used in human and veterinary medicine to treat parasitic nematode
               infection.
            </p>
         </div>
         <div class="sect1" lang="en">
            <div class="titlepage">
               <div>
                  <div>
                     <h2 class="title" style="clear: both"><a name="sec2"></a>2.&nbsp;Is <span class="emphasis"><em>C. elegans</em></span> a model &#8216;parasite&#8217;?
                     </h2>
                  </div>
               </div>
            </div>
            <p>Parasitic nematodes are not an ideal laboratory animal for many reasons, not least of which is the problem with maintaining
               sometimes complex life-cycles. Thus <span class="emphasis"><em>C. elegans</em></span> has routinely been exploited as a more &#8216;user-friendly&#8217; model system that is also highly tractable to molecular genetic techniques.
               However, the life-style of the free-living worm <span class="emphasis"><em>C. elegans</em></span> is very different to that of the parasites, and therefore parasitologists have given careful thought to its relevance (<a href="#bib24">Geary and Thompson, 2001</a>). In terms of overall &#8216;body plan&#8217; there is no doubt that all the species in the phylum Nematoda exhibit similarity despite
               their very different habitats. More detailed consideration has been given to a comparison of the genetics, e.g., the arrangement
               of the genome, synteny and homology between specific genes (<a href="#bib58">Mitreva et al., 2005</a>). Overall, there would seem to be considerable molecular diversity between the different species in the phylum. It is probably
               safe to conclude that <span class="emphasis"><em>C. elegans</em></span> is no more dissimilar to parasitic nematodes than each individual species of parasite is to another. Using <span class="emphasis"><em>C. elegans</em></span> permits the application of powerful molecular genetic approaches and it has been extensively, and successfully, exploited
               as a model system to define molecular components of signalling pathways that underpin nematode physiology.
            </p>
            <p>Indeed, it could be argued that the most relevant consideration for using <span class="emphasis"><em>C. elegans</em></span> as a model to study anthelmintics is the comparative physiology and pharmacology of the Nematoda. Most anthelmintics target
               the neuromusculature and therefore similarities here become of particular importance. The wiring diagram for the neuromuscular
               system is similar between <span class="emphasis"><em>C. elegans</em></span> and the parasitic nematode <span class="emphasis"><em>Ascaris suum</em></span> (<a href="#bib2">Angstadt, Donmoyer and Stretton, 1989</a>) as are the major neurotransmitters; acetylcholine in the excitatory motorneurones (<a href="#bib38">Johnson and Stretton, 1985</a>), GABA in the inhibitory motorneurones (<a href="#bib39">Johnson and Stretton, 1987</a>) and glutamate providing input onto the motorneurones (<a href="#bib16">Davis, 1998</a>). A striking feature of the pharmacology of the nematode nervous system is the abundance of neuropeptides. The majority,
               conceivably all, of <span class="emphasis"><em>C. elegans</em></span> neurones express neuropeptides along with their classical neurotransmitters (for review see <a href="#bib53">Li, 2005</a>). Many of these peptides have potent effects in parasitic nematodes, specifically on musculature which regulates vital nematode
               processes including feeding, locomotion and egg-laying (<a href="#bib10">Brownlee, Holden-Dye and Walker, 2000</a>). Further evidence for an important functional role for peptidergic signalling has been provided by analysis of <span class="emphasis"><em>C. elegans</em></span> mutants. In these studies mutants for the enzymes involved in the processing of neuropeptides, the proconvertase <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=egl-3;class=Gene" target="_blank">egl-3</a></em></span> (<a href="#bib44">Kass et al., 2001</a>) and carboxypeptidase <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=egl-21;class=Gene" target="_blank">egl-21</a></em></span> (<a href="#bib37">Jacob and Kaplan, 2003</a>), have been shown to be severely depleted in neuropeptide content (<a href="#bib36">Husson et al., 2006</a>) and to have altered behaviours consistent with the idea that neuropeptides have modulatory roles within the neural networks
               that direct a range of important worm behaviours.
            </p>
            <p>Neuropeptides are present throughout the animal phyla and also subserve pivotal roles in the nervous systems of the mammalian
               hosts of parasitic nematodes. However, neuropeptides, unlike the small molecule &#8216;classical&#8217; transmitters e.g. acetylcholine,
               have diverged considerably in structure during evolution and this presents the promise that drugs targeting peptidergic signalling
               in nematodes may have low mammalian toxicity. There has thus been considerable interest in the prospect of developing peptidomimetics
               as a novel approach for nematode control. A comparative analysis of the neuropeptide content for a range of nematodes has
               been comprehensively reviewed (<a href="#bib59">McVeigh et al., 2005</a>) and may become an important consideration if this strategy is to be pursued.
            </p>
         </div>
         <div class="sect1" lang="en">
            <div class="titlepage">
               <div>
                  <div>
                     <h2 class="title" style="clear: both"><a name="sec3"></a>3.&nbsp;Approaches for the study of anthelmintics in <span class="emphasis"><em>C. elegans</em></span></h2>
                  </div>
               </div>
            </div>
            <p>There is a large body of literature describing the study of bioactive compounds in <span class="emphasis"><em>C. elegans</em></span> and the proposal to use it for the study of anthelmintics precedes the publication of the <span class="emphasis"><em>C. elegans</em></span> genome sequence by nearly 20 years. <a href="#bib66">Rand and Johnson (1995</a>) coined the term &#8216;genetic pharmacology&#8217; to describe this approach. These studies generally hinge on the ability of a drug
               to elicit a significant, ideally quantifiable, change in the worm's growth, development, metabolism, and/or behaviour. Pharmacokinetic
               considerations include the method and duration of drug exposure. For the vast majority of experiments the anthelmintics are
               applied to intact <span class="emphasis"><em>C. elegans</em></span>. There are thus two ways in which the drug can gain access to target tissues, namely by ingestion or by diffusion across
               the cuticle. In this regard it should be noted that for many drugs the cuticle presents a significant permeability barrier.
               Thus the lipophilicity of drugs has a strong bearing on the concentration that is achieved in target tissues following external
               application. It is not uncommon for polar drugs to be applied at a concentration 1000 fold higher than their predicted affinity
               for the target. It may be possible to ameliorate this problem to some extent by employing animals that have a compromised
               cuticle (<a href="#bib26">Gravato-Nobre et al., 2005</a>). Once the effect of a particular drug on <span class="emphasis"><em>C. elegans</em></span> has been defined, two different strategies may be adopted to investigate the molecular basis for its biological activity.
               The first follows a hypothesis led approach in which strains with mutations in genes of known function are tested for altered
               sensitivity to the drug. The alternate strategy is to conduct a forward genetic screen. This is a powerful and objective approach
               that provides novel insight into the signalling pathways that mediate anthelmintic action. Often the impact of these studies
               extends beyond the interests of parasitologists and into the broader context of cellular and molecular neuroscience. This
               is because the vast majority of anthelmintics exert their effects in the neuromuscular system and key transduction molecules
               in the nervous system are highly conserved across the phyla from worm to human. Thus anthelmintic resistance screens can promote
               the discovery and characterisation of genes that have important roles in neurotransmission. An excellent example of the utility
               of this approach is provided by genetic screens employing the organophosphate cholinesterase inhibitors, in particular aldicarb.
               The detail of these studies is beyond the scope of this review as organophosphates are not widely used as anthelmintics. (Toxicity
               limits their use to highly regulated applications for plant parasitic nematodes). However, aldicarb screens provide an excellent
               example of &#8216;genetic pharmacology&#8217; and the interested reader is directed to <a href="#bib61">Nguyen et al., 1995</a>; <a href="#bib57">Miller et al., 1996</a>; and <a href="#bib72">Seiburth et al., 2005</a>.
            </p>
         </div>
         <div class="sect1" lang="en">
            <div class="titlepage">
               <div>
                  <div>
                     <h2 class="title" style="clear: both"><a name="sec4"></a>4.&nbsp;Classes of anthelmintic drugs
                     </h2>
                  </div>
               </div>
            </div>
            <p>Anthelmintics are separated into classes on the basis of similar chemical structure and mode of action. There are only a few
               main classes and each is briefly discussed in turn below. For the most part, information on the physiological and pharmacological
               actions of anthelmintics has been obtained from studies on the large parasitic nematode <span class="emphasis"><em>A. suum</em></span>. <span class="emphasis"><em>C. elegans</em></span>, on the other hand, has been valuable in defining molecular targets.
            </p>
            <div class="sect2" lang="en">
               <div class="titlepage">
                  <div>
                     <div>
                        <h3 class="title"><a name="sec4_1"></a>4.1.&nbsp;Piperazine
                        </h3>
                     </div>
                  </div>
               </div>
               <p>Piperazine was first used as an anthelmintic in the 1950s and it is still the active constituent of over the counter remedies
                  for thread worm infection in children. Its mode of action has primarily been studied in <span class="emphasis"><em>A. suum</em></span>. There is surprisingly no literature on its action in <span class="emphasis"><em>C. elegans</em></span> though there is no indication that it acts differently from its effects in <span class="emphasis"><em>A. suum</em></span>. In <span class="emphasis"><em>A. suum</em></span> it acts as a weak GABA-mimetic and causes a flaccid, reversible paralysis of body wall muscle. Single channel recordings
                  provide evidence that it is a low efficacy, partial agonist at GABA-gated chloride channels (<a href="#bib54">Martin, 1985</a>).
               </p>
            </div>
            <div class="sect2" lang="en">
               <div class="titlepage">
                  <div>
                     <div>
                        <h3 class="title"><a name="sec4_2"></a>4.2.&nbsp;Benzimidazoles
                        </h3>
                     </div>
                  </div>
               </div>
               <p>The first of this class, thiabendazole, was discovered in 1961 and subsequently a number of further benzamidazoles were introduced
                  as broad spectrum anthelmintics. There is an extensive literature on these compounds reporting a number of different biochemical
                  effects. Nonetheless, it is clear that their anthelmintic efficacy is due to their ability to compromise the cytoskeleton
                  through a selective interaction with <span class="symbol">&#946;</span>-tubulin (<a href="#bib6">Borgers and de Nollin, 1975</a>; for review see <a href="#bib49">Lacey, 1990</a>). The effects of benzimidazoles on <span class="emphasis"><em>C. elegans</em></span>, which include impaired locomotion, reproduction and a detrimental effect on oocytes, are consistent with disruption of processes
                  requiring integral microtubules. The sensitivity of <span class="emphasis"><em>C. elegans</em></span> to benzimidazoles is mediated by a single gene, <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=ben-1;class=Gene" target="_blank">ben-1</a></em></span>, which encodes <span class="symbol">&#946;</span>-tubulin (<a href="#bib18">Driscoll et al., 1989</a>). This has provided a platform to investigate the molecular basis of benzimidazole resistance in parasitic nematodes. It
                  has been noted that benzimidazole resistance in <span class="emphasis"><em>Haemonchus contortus</em></span> seems to be associated with the presence of specific alleles for <span class="symbol">&#946;</span>-tubulin in the drug resistant isolates (<a href="#bib47">Kwa et al., 1994</a>). Whether or not a specific <span class="symbol">&#946;</span>-tubulin isoform could confer resistance to the drug was tested by experiments which showed that the sensitivity of <span class="emphasis"><em>C. elegans</em></span> <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=ben-1;class=Gene" target="_blank">ben-1</a></em></span> mutants to benzimidazole can be rescued by expressing a <span class="emphasis"><em>H. contortus</em></span> allele of <span class="symbol">&#946;</span>-tubulin from benzimidazole susceptible isolates but cannot be rescued by the allele present in the resistant isolates (<a href="#bib48">Kwa et al., 1995</a>). This unequivocally demonstrated that a single amino acid sustitution, Y for F, in <span class="symbol">&#946;</span>-tubulin, can confer anthelmintic resistance. This is the first elegant example of a 'model hopping' approach in which the
                  genetic tractability of <span class="emphasis"><em>C. elegans</em></span> is directly exploited to define gene function in a parasitic worm.
               </p>
            </div>
            <div class="sect2" lang="en">
               <div class="titlepage">
                  <div>
                     <div>
                        <h3 class="title"><a name="sec4_3"></a>4.3.&nbsp;Levamisole, pyrantel and morantel
                        </h3>
                     </div>
                  </div>
               </div>
               <p>These anthelmintics are nicotinic receptor agonists (<a href="#bib1">Aceves et al., 1970</a>; <a href="#bib3">Aubry et al., 1970</a>) and elicit spastic muscle paralysis due to prolonged activation of the excitatory nicotinic acetylcholine (nACh) receptors
                  on body wall muscle. Their precise mode of action has been carefully studied at the single-channel level on the body wall
                  muscle preparation of <span class="emphasis"><em>A. suum</em></span> (see <a href="#bib55">Martin et al., 2005</a> for review). Pharmacological analysis has provided evidence for subtypes of nACh receptor (<a href="#bib64">Qian et al., 2006</a>), an N-type (preferentially activated by nicotine), a B-type (preferentially activated by bephenium) and an L-type (preferentially
                  activated by levamisole and associated with levamisole resistance). Levamisole, and related compounds, also cause spastic
                  paralysis and egg-laying in <span class="emphasis"><em>C. elegans</em></span>. Indeed, recordings from <span class="emphasis"><em>C. elegans</em></span> body wall muscle using levamisole and nicotine as agonists have provided further evidence that there are muscle subtypes
                  of nACh receptor and that these subtypes have different nACh receptor subunit compositions. At least four subunits, <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-38;class=Gene" target="_blank">unc-38</a>, <a href="http://www.wormbase.org/db/get?name=unc-29;class=Gene" target="_blank">unc-29</a>, <a href="http://www.wormbase.org/db/get?name=unc-63;class=Gene" target="_blank">unc-63</a></em></span> and <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lev-1;class=Gene" target="_blank">lev-1</a></em></span> contribute to the levamisole receptor (<a href="#bib13">Culetto et al., 2004</a>; for further information on the nACh receptor subunit family see <a href="#bib65">Rand, 2007</a>). Thus, these anthelmintics are providing pharmacological tools to dissect subtypes and stoichiometries of native nematode
                  nicotinic receptors.
               </p>
               <p>Perhaps more importantly, levamisole has been extremely productive in forward genetic screens. In the earliest studies tetramisole
                  was used (<a href="#bib7">Brenner, 1974</a>) and later this was replaced by the more active isomer, levamisole (<a href="#bib52">Lewis et al., 1980</a>). These screens have provided a resource of mutants that have been used over the last two decades to assign function to genes
                  expressed at the neuromuscular junction. Some of these are nACh receptor subunits, but others interestingly are not and serve
                  to either regulate nicotinic receptors or muscle function (see <a href="#table2" title="Table 2. A summary of gene function for C. elegans levamisole resistant mutants.">Table 2</a>).
               </p>
               <div class="table"><a name="table2"></a><p class="title"><span class="bold"><strong>Table 2. A summary of gene function for</strong></span> <span class="emphasis"><em><span class="bold"><strong>C. elegans</strong></span></em></span> <span class="bold"><strong>levamisole resistant mutants.</strong></span></p>
                  <table summary="Table 2. A summary of gene function for C. elegans levamisole resistant mutants." border="1">
                     <colgroup>
                        <col align="left">
                        <col align="left">
                        <col align="left">
                     </colgroup>
                     <thead>
                        <tr>
                           <th align="left">Gene</th>
                           <th align="left">Function</th>
                           <th align="left">Reference</th>
                        </tr>
                     </thead>
                     <tbody>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-38;class=Gene" target="_blank">unc-38</a></em></span><sup>1</sup></td>
                           <td align="left"><span class="symbol">&#945;</span>-like nACh receptor subunit
                           </td>
                           <td rowspan="3" align="left" valign="middle"><a href="#bib19">Fleming et al., 1997</a></td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-29;class=Gene" target="_blank">unc-29</a></em></span><sup>1</sup></td>
                           <td align="left">Non <span class="symbol">&#945;</span>-like nACh receptor subunit
                           </td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lev-1;class=Gene" target="_blank">lev-1</a></em></span><sup>2</sup></td>
                           <td align="left">Non <span class="symbol">&#945;</span>-like nACh receptor subunit
                           </td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-63;class=Gene" target="_blank">unc-63</a></em></span><sup>1</sup></td>
                           <td align="left"><span class="symbol">&#945;</span>-like nACh receptor subunit
                           </td>
                           <td align="left"><a href="#bib13">Culetto et al., 2004</a></td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-22;class=Gene" target="_blank">unc-22</a></em></span><sup>2</sup></td>
                           <td align="left">Twitchin</td>
                           <td align="left"><a href="#bib60">Moerman et al., 1988</a></td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-50;class=Gene" target="_blank">unc-50</a></em></span><sup>1</sup></td>
                           <td align="left">Transmembrane protein required for receptor trafficking.</td>
                           <td align="left">Bessereau<sup>3</sup></td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-68;class=Gene" target="_blank">unc-68</a></em></span><sup>2</sup></td>
                           <td align="left">Ryanodine receptor</td>
                           <td align="left"><a href="#bib56">Maryon et al., 1996</a></td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lev-9;class=Gene" target="_blank">lev-9</a></em></span><sup>2</sup></td>
                           <td align="left">Putative secreted protein required for levamisole nACh receptor clustering</td>
                           <td align="left">Bessereau<sup>3</sup></td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lev-11;class=Gene" target="_blank">lev-11</a></em></span><sup>2</sup></td>
                           <td align="left">Tropomyosin</td>
                           <td align="left"><a href="#bib41">Kagawa et al., 1995</a></td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lev-8;class=Gene" target="_blank">lev-8</a> (<a href="http://www.wormbase.org/db/get?name=acr-13;class=Gene" target="_blank">acr-13</a>)</em></span><sup>2</sup></td>
                           <td align="left"><span class="symbol">&#945;</span>-like nACh receptor subunit
                           </td>
                           <td align="left"><a href="#bib74">Towers et al., 2005</a></td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lev-10;class=Gene" target="_blank">lev-10</a></em></span><sup>2</sup></td>
                           <td align="left">CUB/LDL protein; receptor clustering</td>
                           <td align="left"><a href="#bib21">Gally et al., 2004</a></td>
                        </tr>
                        <tr>
                           <td align="left"><span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=ric-3;class=Gene" target="_blank">ric-3</a></em></span></td>
                           <td align="left">Required for maturation of nACh receptor</td>
                           <td align="left"><a href="#bib31">Halevi et al., 2002</a></td>
                        </tr>
                        <tr>
                           <td colspan="3" align="left">Isolated and identified as levamisole resistant by <sup>1</sup><a href="#bib7">Brenner (1974)</a>, <sup>2</sup><a href="#bib52">Lewis et al. (1980)</a>. <sup>3</sup>Unpublished data, see <a href="http://www.wormbase.org" target="_blank">www.wormbase.org</a></td>
                        </tr>
                     </tbody>
                  </table>
               </div>
            </div>
            <div class="sect2" lang="en">
               <div class="titlepage">
                  <div>
                     <div>
                        <h3 class="title"><a name="sec4_4"></a>4.4.&nbsp;Paraherquamide
                        </h3>
                     </div>
                  </div>
               </div>
               <p>Paraherquamide A and marcfortine A are both members of the oxindole alkaloid family, originally isolated from <span class="emphasis"><em>Penicillium paraherquei</em></span> and <span class="emphasis"><em>Penicillium roqueforti</em></span>, respectively (<a href="#bib81">Zinser et al., 2002</a>). Marcfortine A was found to be active against <span class="emphasis"><em>C. elegans</em></span> in a high throughput screen (<a href="#bib51">Lee et al., 2002</a>). A specific, high affinity binding site for paraherquamide has been identified in a membrane preparation isolated from <span class="emphasis"><em>C. elegans</em></span>, with an apparent Kd of 263nM (<a href="#bib71">Schaeffer et al., 1992</a>). Paraherquamide and its derivative, 2-deoxy-paraherquamide, induce flaccid paralysis in parasitic nematodes, <span class="emphasis"><em>in vitro</em></span>. Pharmacological analysis of the effects of these drugs on acetylcholine-stimulated body wall muscle contractions in <span class="emphasis"><em>A. suum</em></span> muscle strips <span class="emphasis"><em>in vitro</em></span> has shown that they act as typical competitive antagonists, shifting the concentration-response curves to the right in a
                  parallel fashion (<a href="#bib67">Robertson et al., 2002</a>). These drugs have no apparent direct effect on <span class="emphasis"><em>A. suum</em></span> body wall muscle tension or membrane potential (<a href="#bib51">Lee et al., 2002</a>). Paraherquamide also blocks the actions of other nicotinic agonists, but not equipotently (<a href="#bib81">Zinser et al., 2002</a>; <a href="#bib67">Robertson et al., 2002</a>). Interestingly, this antagonist seems to distinguish nicotinic receptor subtypes on the muscle and has a greater affinity
                  for the receptors mediating the response to levamisole and pyrantel, than the receptors that mediate the response to nicotine.
                  One might therefore expect that paraherquamide would be an effective antagonist of the levamisole-selective receptor on <span class="emphasis"><em>C. elegans</em></span> body wall muscle. Importantly, the mode of action of this class of anthelmintics differs from the more established drugs
                  that interfere with cholinergic transmission, e.g., levamisole, in that they act as competitive antagonists rather than cholinomimetics.
                  The use of paraherquamide in forward genetic screens has not yet been reported but could potentially generate interesting
                  new mutants. As it is a competitive inhibitor of the body wall nACh receptor it would be predicted that mutations that increase
                  transmitter release should confer resistance. Thus a forward genetic screen might reveal further negative regulators of neurotransmitter
                  release.
               </p>
            </div>
            <div class="sect2" lang="en">
               <div class="titlepage">
                  <div>
                     <div>
                        <h3 class="title"><a name="sec4_5"></a>4.5.&nbsp;Ivermectin (macrocylic lactones and milbemycins)
                        </h3>
                     </div>
                  </div>
               </div>
               <p>Ivermectin was introduced as an anthelmintic in the 1980s by Merck. It is a semi-synthetic derivative of avermectin which
                  is a large macrocyclic lactone fermentation product of the micro-organism <span class="emphasis"><em>Streptomyces avermitilis</em></span>. It is remarkably potent (~1nM) and persistent in its effect and its discovery enthused other companies to invest in the
                  development of ivermectin analogues which include moxidectin, milbemycin oxime, doramectin, selamectin, abamectin and eprinomectin.
                  Here <span class="emphasis"><em>C. elegans</em></span> played a role as it was employed in a screen for further macrocyclic lactones with ivermectin-like activity (<a href="#bib30">Haber et al., 1991</a>).
               </p>
               <p>Ivermectin elicits a potent and persistent paralysis of nematode pharyngeal (<a href="#bib9">Brownlee, Holden-Dye and Walker, 1997</a>; <a href="#bib62">Pemberton et al., 2001</a>) and body wall musculature (<a href="#bib42">Kass et al., 1980</a>; <a href="#bib43">Kass et al., 1982</a>). It has been shown to interact with a range of ligand-gated ion channels including <span class="symbol">&#945;</span>7 nACh receptors (<a href="#bib46">Krause et al., 1998</a>), acetylcholine-gated chloride channels (<a href="#bib5">Bokisch and Walker, 1986</a>), GABA-gated chloride channels (<a href="#bib68">Robertson, 1989</a>; <a href="#bib34">Holden-Dye and Walker, 1990</a>), histamine-gated chloride channels (<a href="#bib80">Zheng et al., 2002</a>), glycine receptors (<a href="#bib73">Shan et al., 2001</a>) and P2X4 receptors (<a href="#bib45">Khakh et al., 1999</a>). However, it is its high affinity for nematode glutamate-gated chloride channels (GluCl) that correlates with its potent
                  anthelmintic activity. This was defined by the team at Merck which succeeded in expression cloning GluCl<span class="symbol">&#945;</span> and GluCl<span class="symbol">&#946;</span> ion channel subunits from <span class="emphasis"><em>C. elegans</em></span> (<a href="#bib14">Cully et al., 1994</a>). Both subunits were expressed either singly, or together, in <span class="emphasis"><em>Xenopus</em></span> oocytes. GluCl<span class="symbol">&#945;</span> responds to micromolar ivermectin, but not to glutamate whilst GluCl<span class="symbol">&#946;</span> responds to glutamate but not ivermectin. Co-expression of GluCl<span class="symbol">&#945;</span> and GluCl<span class="symbol">&#946;</span> yields a channel which responds to glutamate and is positively allosterically modulated by nanomolar ivermectin. Subsequently
                  a small family of nematode genes encoding GluCl channels has been identified (see <a href="#bib79">Yates, Portillo and Wolstenholme for review, 2003</a>). The nomenclature is confusing as the same genes have been discovered by both homology screening approaches and from forward
                  genetic screens for ivermectin resistance genes. Essentially there are four <span class="emphasis"><em>C. elegans</em></span> genes encoding GluCl<span class="symbol">&#945;</span> subunits, two of which are alternately spliced yielding the GluCl channels: GluCl<span class="symbol">&#945;</span>1 encoded by <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=glc-1;class=Gene" target="_blank">glc-1</a></em></span>; GluCl<span class="symbol">&#945;</span>2A and B encoded by <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-15;class=Gene" target="_blank">avr-15</a></em></span>; GluCl<span class="symbol">&#945;</span>3A and B encoded by <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-14;class=Gene" target="_blank">avr-14</a></em></span>; GluCl<span class="symbol">&#945;</span>4 encoded by <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=glc-3;class=Gene" target="_blank">glc-3</a></em></span>. There is just one GluCl<span class="symbol">&#946;</span> subunit encoded by <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=glc-2;class=Gene" target="_blank">glc-2</a></em></span> and a further gene, <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=glc-4;class=Gene" target="_blank">glc-4</a></em></span>, which is divergent from the genes encoding <span class="symbol">&#945;</span> and <span class="symbol">&#946;</span> subunits. Although the pharmacology of channels assembled from these GluCl subunits has been defined in heterologous expression
                  systems, the important question of the subunit stoichiometry and pharmacology of the native channels is much more poorly defined.
                  Further studies on <span class="emphasis"><em>C. elegans</em></span> are providing a better understanding of this by delineating the expression pattern for GluCl subunits in the nervous system.
                  For example, the pharyngeal muscle expresses <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-15;class=Gene" target="_blank">avr-15</a></em></span> and <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=glc-2;class=Gene" target="_blank">glc-2</a></em></span>, (<a href="#bib17">Dent, Davis and Avery, 1997</a>; <a href="#bib50">Laughton, Lunt and Wolstenholme, 1997</a>). Thus it might be expected that GluCl<span class="symbol">&#945;</span>2 and GluCl<span class="symbol">&#946;</span> subunits co-assemble to form a native ivermectin sensitive channel. Whether or not other subunits contribute to the functional
                  receptor is not yet clear. However, the pharyngeal muscle of <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-15;class=Gene" target="_blank">avr-15</a></em></span> mutants does not respond to ivermectin (<a href="#bib17">Dent, Davis and Avery, 1997</a>; <a href="#bib62">Pemberton et al., 2001</a>) clearly indicating an involvement of GluCl<span class="symbol">&#945;</span>2. An important point to note in terms of the site of anthelmintic action of ivermectin is that although the pharynxes of
                  <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-15;class=Gene" target="_blank">avr-15</a></em></span> mutants are not inhibited by ivermectin, populations of <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-15;class=Gene" target="_blank">avr-15</a></em></span> mutants exposed to ivermectin are still paralyzed. Thus GluCl channels in the pharynx are not required for the paralytic
                  effect. This may also be true for parasitic nematodes. For example, ivermectin has anthelmintic activity against <span class="emphasis"><em>Ascaridia galli</em></span> and yet the pharynx of this species is not inhibited by the drug (<a href="#bib35">Holden-Dye and Walker, 2006</a>). In order to obtain a better understanding of the role of GluCl channels in mediating the paralytic actions of ivermectin
                  it is probably more informative to consider their role in the motornervous system. Currently most information is available
                  for <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-14;class=Gene" target="_blank">avr-14</a></em></span> and <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-15;class=Gene" target="_blank">avr-15</a></em></span>. These genes are expressed in the motor nervous system of <span class="emphasis"><em>C. elegans</em></span> (<a href="#bib17">Dent et al., 1997</a>; <a href="#bib82">Dent et al., 2000</a>) and there is immunostaining for GluCl<span class="symbol">&#945;</span>3A and B in motorneurones of the parasitic nematode <span class="emphasis"><em>H. contortus</em></span>, (<a href="#bib63">Portillo, Jagannathan, Wolstenholme 2003</a>). One role of these GluCl channels in <span class="emphasis"><em>C. elegans</em></span> involves regulation of the duration of forward movement, a well established glutamatergic-regulated behaviour (<a href="#bib8">Brockie and Maricq, 2006</a>). This function may be conserved between <span class="emphasis"><em>C. elegans</em></span> and <span class="emphasis"><em>H. contortus</em></span> as <span class="emphasis"><em>H. contortus</em></span> GluCl<span class="symbol">&#945;</span>3 subunits expressed in <span class="emphasis"><em>C. elegans</em></span> <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-14;class=Gene" target="_blank">avr-14</a></em></span> mutants restore the wild type pattern of movement (<a href="#bib12">Cook et al., 2006</a>). It is most likely that the paralytic action of ivermectin derives from its potent activation of GluCl in the motornervous
                  system of nematodes. However, the precise role of individual GluCl channels in mediating the effects of ivermectin on these
                  circuits is yet to be established. The mechanism of resistance to ivermectin has also been studied in <span class="emphasis"><em>C. elegans</em></span>. High level resistance is a complex phenomenon which requires mutations in at least three genes, namely in <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=glc-1;class=Gene" target="_blank">glc-1</a></em></span>, <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-14;class=Gene" target="_blank">avr-14</a></em></span> and <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-15;class=Gene" target="_blank">avr-15</a></em></span>. Further genes, regulating membrane permeability (<span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=osm-1;class=Gene" target="_blank">osm-1</a></em></span>) and gap junctions (<span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-7;class=Gene" target="_blank">unc-7</a></em></span> and <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-9;class=Gene" target="_blank">unc-9</a></em></span>), are also involved (<a href="#bib82">Dent et al., 2000</a>). Defining the role of GluCl mutations in conferring ivermectin resistance to parasitic nematodes in the field is a less
                  tractable and more controversial problem (<a href="#bib78">Wolstenholme et al., 2004</a>).
               </p>
            </div>
            <div class="sect2" lang="en">
               <div class="titlepage">
                  <div>
                     <div>
                        <h3 class="title"><a name="sec4_6"></a>4.6.&nbsp;Emodepside (cyclodepsipeptides, PF1022A)
                        </h3>
                     </div>
                  </div>
               </div>
               <p>The cyclodepsipeptide molecule, emodepside, is a semi-synthetic derivative of PF1022A, a fermentation product obtained from
                  the fungus, <span class="emphasis"><em>Mycelia sterilia</em></span>, of <span class="emphasis"><em>Camelia japonica</em></span>. Its discovery and anthelmintic activity has recently been reviewed (<a href="#bib32">Harder, von Samson-Himmelstjerna, 2002</a>). It is effective against isolates of parasites that are resistant to benzimidazole, levamisole and ivermectin indicating,
                  importantly, that it has a novel mode of action. The molecule has pore-forming properties in planar lipids, however, this
                  does not appear to be important in conferring its anthelmintic potency as an optical isomer of emodepside, with similar pore
                  forming properties, does not have anthelmintic action. Thus it would appear that it may act through stereospecific binding
                  to a receptor. Studies in <span class="emphasis"><em>A. suum</em></span> have highlighted muscle paralysis and point to a calcium- and potassium-dependent mechanism of action (<a href="#bib76">Willson et al., 2003</a>). A candidate receptor for the cyclodepsipeptides has been cloned from a <span class="emphasis"><em>H. contortus</em></span> cDNA library by immunoscreening with an antibody to PF1022 A. This receptor, designated HC110R, has been expressed in HEK293
                  cells and shown to gate calcium flux in a PF1022 A-dependent manner (<a href="#bib69">Saeger et al., 2001</a>). It has homology to mammalian latrophilins, a class of G protein-coupled receptors which bind the neurotoxin, latrotoxin.
                  Latrotoxin paralyses mammals by triggering neurotransmitter release, and thus the identification of latrophilin as an emodepside
                  receptor raised the intriguing possibility that emodepside may cause paralysis of nematodes by stimulating excessive neurotransmitter
                  release at neuromuscular sites.
               </p>
               <p><span class="emphasis"><em>C. elegans</em></span> is very susceptible to the effects of emodepside at nanomolar concentrations (<a href="#bib11">Bull et al., 2007</a>). The effects include slowed development, inhibition of pharyngeal pumping, decreased locomotion (forward movement is most
                  affected at low concentrations), and inhibition of egg-laying leading to &#8216;bagging&#8217; in adult hermaphrodites. Thus <span class="emphasis"><em>C. elegans</em></span> has provided an excellent model in which to define the molecular target, or targets, through which emodepside exerts its
                  pleiotropic actions and indeed, to test whether latrophilins are involved.
               </p>
               <p>There are two genes encoding candidate latrophilins in <span class="emphasis"><em>C. elegans</em></span>, <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lat-1;class=Gene" target="_blank">lat-1</a></em></span> and <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lat-2;class=Gene" target="_blank">lat-2</a></em></span>. The role of these latrophilins in mediating the inhibitory effects of emodepside on feeding and locomotion has been investigated
                  using RNAi and gene knockouts (<a href="#bib77">Willson et al., 2004</a>; <a href="#bib11">Bull et al., 2007</a>; <a href="#bib29">Guest et al., 2007</a>). The pharyngeal system of <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lat-1;class=Gene" target="_blank">lat-1</a></em></span> mutants show a reduced sensitivity to emodepside but their locomotor activity is inhibited in a similar fashion to wild-type
                  animals (<a href="#bib29">Guest et al., 2007</a>). Emodepside does not exert its inhibitory effect on locomotion through the other latrophilin, <a href="http://www.wormbase.org/db/get?name=LAT-2;class=Protein" target="_blank">LAT-2</a>, as <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lat-2;class=Gene" target="_blank">lat-2</a></em></span> mutants respond just like wild-type animals. Nor is there redundancy of function between <a href="http://www.wormbase.org/db/get?name=LAT-1;class=Protein" target="_blank">LAT-1</a> and <a href="http://www.wormbase.org/db/get?name=LAT-2;class=Protein" target="_blank">LAT-2</a> in terms of the effect of emodepside on locomotion, as the double mutant <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lat-2;class=Gene" target="_blank">lat-2</a>,lat-1</em></span> responds to emodepside in a similar fashion to the single mutant, <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lat-1;class=Gene" target="_blank">lat-1</a></em></span> (<a href="#bib29">Guest et al., 2007</a>). Clearly, emodepside has latrophilin-independent actions.
               </p>
               <p>Recently, forward genetic screens have provided further insight into the mechanism through which emodepside exerts its inhibitory
                  action on <span class="emphasis"><em>C. elegans</em></span> muscle. A chemical mutagenesis screen of twenty thousand genomes for mutants that could move and propagate on micromolar
                  emodepside recovered nine alleles of a single gene, <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=slo-1;class=Gene" target="_blank">slo-1</a></em></span>. Strains carrying functional null alleles of <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=slo-1;class=Gene" target="_blank">slo-1</a></em></span> are highly resistant to the inhibitory effects of emodepside on locomotion and feeding. Furthermore, strains carrying gain-of-function
                  alleles of <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=slo-1;class=Gene" target="_blank">slo-1</a></em></span> behave in a similar manner to emodepside-treated animals but are not themselves emodepside hypersensitive. These data strongly
                  support the contention that emodepside activates a SLO-1-dependent pathway to bring about neuromuscular inhibition.
               </p>
               <p><a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a> is a calcium-activated potassium channel (<a href="#bib75">Wang et al. 2001</a>) homologous to the mammalian BK channels. Thus the discovery of <a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a> as an important effector for emodepside resonates with earlier work on <span class="emphasis"><em>Ascaris</em></span> muscle which showed a calcium and potassium-dependent hyperpolarisation (<a href="#bib76">Willson et al., 2003</a>). This channel is highly conserved throughout the animal phyla and plays a pivotal role in regulating neuronal and muscle
                  cell excitability (for review, <a href="#bib70">Salkoff et al., 2006</a>). In <span class="emphasis"><em>C. elegans</em></span> it is widely expressed in the nervous system and body wall muscle, but not in pharyngeal muscle. By expressing a wild-type
                  copy of <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=slo-1;class=Gene" target="_blank">slo-1</a></em></span> in specific subsets of cells in a <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=slo-1;class=Gene" target="_blank">slo-1</a></em></span> null background it has been shown that emodepside can inhibit locomotor activity when <a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a> is present in neurones or body wall muscle but it can only inhibit feeding if <a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a> is present in neurones (<a href="#bib29">Guest et al., 2007</a>). Earlier studies showed that mutations in a number of genes encoding synaptic proteins confer altered sensitivity to the
                  effect of emodepside on feeding consistent with the idea that it acts in the neuronal network to disrupt rhythmic feeding
                  behaviour (<a href="#bib77">Willson et al., 2004</a>).
               </p>
               <p>The discovery of <a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a> as a mediator of the inhibitory effects of emodepside on <span class="emphasis"><em>C. elegans</em></span> is an important development in this field which in the light of ivermectin resistance has an urgent need for such breakthroughs.
                  In the broader context, there is an emerging body of evidence indicating that BK channels such as <a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a> may play a pivotal role in conferring sensitivity to neuroactive drugs, including ethanol and local anaesthetics (<a href="#bib15">Davies et al., 2003</a>; <a href="#bib33">Hawasli et al., 2004</a>) and in regulating the pattern of activity of neural networks (<a href="#bib70">Salkoff et al., 2006</a>). Thus, an additional and valuable facet of these studies is that emodepside provides a new tool to dissect the functional
                  role of <a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a> in neural networks using the power of molecular genetics in <span class="emphasis"><em>C. elegans</em></span>.
               </p>
            </div>
            <div class="sect2" lang="en">
               <div class="titlepage">
                  <div>
                     <div>
                        <h3 class="title"><a name="sec4_7"></a>4.7.&nbsp;Nitazoxanide
                        </h3>
                     </div>
                  </div>
               </div>
               <p>Nitazoxanide, a pyruvate ferredoxin oxidoreductase inhibitor, acts against a broad spectrum of protozoa and helminths that
                  occur in the intestinal tract. It is currently used for the treatment of protozoal infections (and is therefore not listed
                  in <a href="#table1" title="Table 1. Key drugs registered for the treatment of parasitic worms in humans.">Table 1</a>). The site of action of this compound has not been established in nematodes although anaerobic electron transport enzymes
                  may be a potential target (<a href="#bib25">Gilles and Hoffman 2002</a>). The effect of nitazoxanide has been examined on growth and development of <span class="emphasis"><em>C. elegans</em></span> (<a href="#bib20">Fonseca-Salamanca et al., 2003</a>). After seven days culture, nitazoxanide 100 &#956;M, only reduced population growth by 33%. In contrast mebendazole, 5&#956;M, and
                  albendazole, 1 &#956;M, reduced growth by over 90%. Nitazoxanide, 100 &#956;M, had no effect on either embryonation or hatching in <span class="emphasis"><em>Heligmosomoides polygyrus.</em></span> Therefore the efficacy of this compound is relatively low compared to other anthelmintic agents.
               </p>
            </div>
         </div>
         <div class="sect1" lang="en">
            <div class="titlepage">
               <div>
                  <div>
                     <h2 class="title" style="clear: both"><a name="sec5"></a>5.&nbsp;The future
                     </h2>
                  </div>
               </div>
            </div>
            <p>A particular challenge for companies engaged in anthelmintic research, not shared by its more wealthy cousin the pharmaceutical
               industry, is that for the anthelmintic market cost-effectiveness is a prime concern. Furthermore, for tropical medicine, anthelmintics
               must be used in mass chemotherapy programmes in regions where clinical support is sparse and therefore drugs need to be very
               well tolerated in humans. For the last twenty years a small repertoire of drugs, especially ivermectin, has addressed this
               need. Indeed, ivermectin has been hugely successful both in veterinary and tropical medicine and its use in Africa has transformed
               the lives of populations previously devastated by the tropical disease Onchocerciasis (river blindness).
            </p>
            <p>The most pressing concern for the future is the emergence of resistance to all the currently used anthelmintics, including
               ivermectin. <span class="emphasis"><em>C. elegans</em></span> was pivotal in defining the mode of action for the majority of these drugs and can also contribute to understanding mechanisms
               of resistance especially through the adoption of a &#8216;model-hopping&#8217; approach whereby the functionality of parasite genes is
               assessed by using <span class="emphasis"><em>C. elegans</em></span> as an expression system.
            </p>
            <p>Of equal importance for the future is the use of <span class="emphasis"><em>C. elegans</em></span> as a model system for drug discovery. It is to be hoped that this will provide new anthelmintics that have novel modes of
               action and thus will circumvent the problem of anthelmintic resistance. The advent of RNAi and high throughput techniques
               for analysis of <span class="emphasis"><em>C. elegans</em></span> has led to renewed interest in drug discovery using chemical genetic screens (<a href="#bib4">Behm et al., 2005</a>; <a href="#bib40">Jones, Buckingham and Sattelle, 2005</a>). The molecular targets for the drugs that come out of these screens, or from other pipe-lines, can be defined using the
               powerful approach of forward genetics in <span class="emphasis"><em>C. elegans</em></span> and may uncover new effectors for anthelmintic action. Recently advances have been made exploiting <span class="emphasis"><em>C. elegans</em></span> for such mode of action studies and have highlighted a new effector, <a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a>, in the anthelmintic action of the latest drug to hit the market, emodepside (Profender).
            </p>
            <p>More targeted approaches to anthelmintic drug discovery are also ongoing. These are providing fundamental information on nematode
               neurobiology with the aim of identifying signalling molecules that have pivotal roles in neural circuits that underpin vital
               behaviours. Here it will be interesting to see whether or not the ambition to target peptidergic signalling pathways translates
               into a marketable drug (<a href="#bib28">Greenwood, Williams and Geary, 2005</a>).
            </p>
            <p>In conclusion, it is clear that <span class="emphasis"><em>C. elegans</em></span> has, and will continue to prove an exceptionally tractable and informative model system for parasitic nematodes and mode
               of action studies for anthelmintics. The future holds the promise that <span class="emphasis"><em>C. elegans</em></span> may also directly contribute to drug discovery. These efforts are of utmost importance in view of the increasing threat to
               live-stock and humans from anthelmintic resistant strains of parasite.
            </p>
         </div>
         <div class="sect1" lang="en">
            <div class="titlepage">
               <div>
                  <div>
                     <h2 class="title" style="clear: both"><a name="d0e1307"></a>6.&nbsp;References
                     </h2>
                  </div>
               </div>
            </div>
            <div class="bibliography">
               <div class="bibliomixed"><a name="bib1"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Aceves, J., Erlij, D., and Martinez-Maranon, R. (1970). The mechanism of the paralysing action of tetramisole on <span class="emphasis"><em>Ascaris</em></span> somatic muscle. Br. J. Pharmacol. <span class="emphasis"><em>38</em></span>, 602&#8211;607.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=5445688&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib2"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Angstadt, J.D., Donmoyer, J.E., and Stretton, A.O. (1989). Retrovesicular ganglion of the nematode <span class="emphasis"><em>Ascaris</em></span>. J. Comp. Neurol. <span class="emphasis"><em>284</em></span>, 374&#8211;388.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=2754041&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1002/cne.902840305" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib3"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Aubry, M.L., Cowell, P., Davey, M.J., and Shevde, S. (1970). Aspects of the pharmacology of a new anthelmintic: pyrantel.
                        Br. J. Pharmacol. <span class="emphasis"><em>38</em></span>, 332&#8211;344.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=5417856&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib4"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Behm, C.A., Bendig, M.M., McCarter, J.P., and Sluder, A.E. (2005). RNAi-based discovery and validation of new drug targets
                        in filarial nematodes. Trends Parasitol. <span class="emphasis"><em>21</em></span>, 97&#8211;100.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15734653&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.pt.2004.12.003" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib5"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Bokisch, A.J., and Walker, R.J. (1986). The action of Avermectin (MK 936) on identified central neurones from <span class="emphasis"><em>Helix</em></span> and its interaction with acetylcholine and gamma-aminobutyric acid (GABA) responses. Comp. Biochem. Physiol. C, Comp. Pharmacol.
                        <span class="emphasis"><em>84</em></span>, 119&#8211;125.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=2873943&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/0742-8413(86)90176-3" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib6"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Borgers, M., and De Nollin, S. (1975). Ultrastructural changes in <span class="emphasis"><em>Ascaris suum</em></span> intestine after mebendazole treatment <span class="emphasis"><em>in vivo</em></span>. J. Parasitol. <span class="emphasis"><em>61</em></span>, 110&#8211;122.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1117352&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.2307/3279120" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib7"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Brenner, S. (1974). The genetics of <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Genetics <span class="emphasis"><em>77</em></span>, 71&#8211;94.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=4366476&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib8"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Brockie, P.J., and Maricq, A.V. (January 19, 2006). Ionotropic glutamate receptors: genetics, behavior and electrophysiology,
                        <span class="emphasis"><em>WormBook</em></span>, ed. The <span class="emphasis"><em>C. elegans</em></span> Research Community, WormBook, doi/10.1895/wormbook. 1.61.1, <a href="http://www.wormbook.org" target="_blank">http://www.wormbook.org</a>.</span>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib9"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Brownlee, D.J., Holden-Dye, L., and Walker, R.J. (1997). Action of the anthelmintic ivermectin on the pharyngeal muscle of
                        the parasitic nematode, <span class="emphasis"><em>Ascaris suum</em></span>. Parasitology <span class="emphasis"><em>115</em></span>, 553&#8211;561.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9368907&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1017/S0031182097001601" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib10"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Brownlee, D., Holden-Dye, L., and Walker R.J. (2000). The range and biological activity of FMRFamide-related peptides and
                        classical neurotransmitters in nematodes. Adv. Parasitol. <span class="emphasis"><em>45</em></span>, 109&#8211;180.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10751940&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib11"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Bull, K., Cook, A., Hopper, N.A., Harder, A., Holden-Dye, L., and Walker, R.J. (2006). Effects of the novel anthelmintic emodepside
                        on the locomotion, egg-laying behaviour and development of <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Int. J. Parasitol. <span class="emphasis"><em>37</em></span>, 627&#8211;636.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17157854&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.ijpara.2006.10.013" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib12"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Cook, A., Aptel, N., Portillo, V., Siney, E., Sihota, R., Holden-Dye L., and Wolstenholme, A. (2006). <span class="emphasis"><em>Caenorhabditis elegans</em></span> ivermectin receptors regulate locomotor behaviour and are functional orthologues of <span class="emphasis"><em>Haemonchus contortus</em></span> receptors. Mol. Biochem. Parasitol. <span class="emphasis"><em>147</em></span>, 118&#8211;125.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16527366&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.molbiopara.2006.02.003" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib13"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Culetto, E., Baylis, H.A., Richmond, J.E., Jones, A.K., Fleming, J.T., Squire, M.D., Lewis, J.A., and Sattelle, D.B. (2004).
                        The <span class="emphasis"><em>Caenorhabditis elegans <a href="http://www.wormbase.org/db/get?name=unc-63;class=Gene" target="_blank">unc-63</a></em></span> gene encodes a levamisole-sensitive nicotinic acetylcholine receptor alpha subunit. J Biol Chem. <span class="emphasis"><em>279</em></span>, 42476&#8211;42483.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15280391&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1074/jbc.M404370200" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib14"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Cully, D.F., Vassilatis, D.K., Liu, K.K., Paress, P.S., Van der Ploeg, L.H., Schaeffer, J.M., and Arena, J.P. (1994). Cloning
                        of an avermectin-sensitive glutamate-gated chloride channel from <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Nature <span class="emphasis"><em>371</em></span>, 707&#8211;711.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7935817&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1038/371707a0" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib15"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Davies, A.G., Pierce-Shimomura, J.T., Kim, H., VanHoven, M.K., Thiele, T.R., Bonci, A., Bargmann, C.I., and McIntire, S.L.
                        (2003). A central role of the BK potassium channel in behavioral responses to ethanol in <span class="emphasis"><em>C. elegans</em></span>. Cell <span class="emphasis"><em>115</em></span>, 655&#8211;666.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=14675531&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/S0092-8674(03)00979-6" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib16"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Davis, R.E. (1998). Neurophysiology of glutamatergic signalling and anthelmintic action in <span class="emphasis"><em>Ascaris suum</em></span>: pharmacological evidence for a kainate receptor. Parasitology <span class="emphasis"><em>116</em></span>, 471&#8211;486.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9614330&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1017/S0031182098002467" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib17"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Dent, J.A., Davis, M.W., and Avery, L. (1997). <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=avr-15;class=Gene" target="_blank">avr-15</a></em></span> encodes a chloride channel subunit that mediates inhibitory glutamatergic neurotransmission and ivermectin sensitivity in
                        <span class="emphasis"><em>Caenorhabditis elegans</em></span>. EMBO J. <span class="emphasis"><em>16</em></span>, 5867&#8211;5879.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9312045&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1093/emboj/16.19.5867" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib82"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Dent, J.A., Smith, M.M., Vassilatis, D.K., and Avery, L. (2000). The genetics of ivermectin resistance in <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Proc. Natl. Acad. Sci. U.S.A. <span class="emphasis"><em>97</em></span>, 2674&#8211;2679.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10716995&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1073/pnas.97.6.2674" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib18"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Driscoll, M., Dean, E., Reilly, E., Bergholz, E., and Chalfie, M. (1989). Genetic and molecular analysis of a <span class="emphasis"><em>Caenorhabditis elegans</em></span> beta-tubulin that conveys benzimidazole sensitivity. J. Cell Biol. <span class="emphasis"><em>109</em></span>, 2993&#8211;3003.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=2592410&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1083/jcb.109.6.2993" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib19"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Fleming, J.T., Squire, M.D., Barnes, T.M., Tornoe, C., Matsuda, K., Ahnn, J., Fire, A., Sulston, J.E., Barnard, E.A., Sattelle,
                        D.B., and Lewis, J.A. (1997). <span class="emphasis"><em>Caenorhabditis elegans</em></span> levamisole resistance genes <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=lev-1;class=Gene" target="_blank">lev-1</a>, <a href="http://www.wormbase.org/db/get?name=unc-29;class=Gene" target="_blank">unc-29</a></em></span>, and <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-38;class=Gene" target="_blank">unc-38</a></em></span> encode functional nicotinic acetylcholine receptor subunits. J. Neurosci. <span class="emphasis"><em>17</em></span>, 5843&#8211;5857.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9221782&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib20"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Fonseca-Salamanca, F., Martinez-Grueiro, M.M., and Martinez-Fernandez, A.R. (2003). Nematocidal activity of nitazoxanide in
                        laboratory models. Parasitol. Res. <span class="emphasis"><em>91</em></span>, 321&#8211;324.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=14574563&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1007/s00436-003-0974-7" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib21"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Gally, C., Eimer, S., Richmond, J.E., and Bessereau, J.L. (2004). A transmembrane protein required for acetylcholine receptor
                        clustering in <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Nature <span class="emphasis"><em>431</em></span>, 578&#8211;582.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15457263&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1038/nature02893" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib22"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Geary, T.G. (2005). Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol. <span class="emphasis"><em>21</em></span>, 530&#8211;532.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16126457&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.pt.2005.08.014" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib23"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Geary T.G., Sangster, N.C., and Thompson, D.P. (1999). Frontiers in anthelmintic pharmacology. Vet. Parasitol. <span class="emphasis"><em>84</em></span>, 275&#8211;295.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10456419&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/S0304-4017(99)00042-4" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib24"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Geary T.G., and Thompson, D.P. (2001). <span class="emphasis"><em>Caenorhabditis elegans</em></span>: how good a model for veterinary parasites? Vet. Parasitol. <span class="emphasis"><em>101</em></span>, 371&#8211;386.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11707307&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/S0304-4017(01)00562-3" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib25"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Gilles, H.M., and Hoffman, P.S. (2002). Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol.
                        <span class="emphasis"><em>18</em></span>, 95&#8211;97.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11854075&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/S1471-4922(01)02205-X" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib26"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Gravato-Nobre, M.J., Nicholas, H.R., Nijland, R., O'Rourke, D., Whittington, D.E., Yook, K.J., and Hodgkin, J. (2005). Multiple
                        genes affect sensitivity of <span class="emphasis"><em>Caenorhabditis elegans</em></span> to the bacterial pathogen <span class="emphasis"><em>Microbacterium nematophilum</em></span>. Genetics <span class="emphasis"><em>171</em></span>, 1033&#8211;1045.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16079230&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1534/genetics.105.045716" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib27"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Greenberg, RM. (2005). Ca<sup>2+</sup> signalling, voltage-gated Ca<sup>2+</sup> channels and praziquantel in flatworm neuromusculature. Parasitology <span class="emphasis"><em>131</em></span>, S97&#8211;S108.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16569296&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1017/S0031182005008346" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib28"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Greenwood, K., Williams, T., and Geary, T. (2005). Nematode neuropeptide receptors and their development as anthelmintic screens.
                        Parasitology <span class="emphasis"><em>131</em></span>, S169&#8211;S177.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16569288&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1017/S003118200500819X" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib29"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Guest, M., Bull, K., Walker, R.J., Amliwala, K., O'Connor, V., Harder, A., Holden-Dye, L., and Hopper, N.A. (2007). The calcium-activated
                        potassium channel, <a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a>, is required for the action of the novel cyclo-octadepsipeptide anthelmintic, emodepside, in <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Int. J. Parasitol. <span class="emphasis"><em>37</em></span>, 1577&#8211;1588.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17583712&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.ijpara.2007.05.006" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib30"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Haber, C.L., Heckaman, C.L., Li, G.P., Thompson, D.P., Whaley, H.A., and Wiley, V.H. (1991). Development of a mechanism of
                        action-based screen for anthelmintic microbial metabolites with avermectin-like activity and isolation of milbemycin-producing
                        <span class="emphasis"><em>Streptomyces</em></span> strains. Antimicrob. Agents Chemother. <span class="emphasis"><em>35</em></span>, 1811&#8211;1817.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1719935&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib31"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Halevi, S., McKay, J., Palfreyman, M., Yassin, L., Eshel, M., Jorgensen, E., and Treinin, M. (2002). The <span class="emphasis"><em>C. elegans <a href="http://www.wormbase.org/db/get?name=ric-3;class=Gene" target="_blank">ric-3</a></em></span> gene is required for maturation of nicotinic acetylcholine receptors. EMBO J. <span class="emphasis"><em>21</em></span>, 1012&#8211;1020.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11867529&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1093/emboj/21.5.1012" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib32"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Harder, A., and von Samson-Himmelstjerna, G. (2002). Cyclooctadepsipeptides--a new class of anthelmintically active compounds.
                        Parasitol. Res. <span class="emphasis"><em>88</em></span>, 481&#8211;488.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12107468&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1007/s00436-002-0619-2" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib33"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Hawasli, A.H., Saifee, O., Liu, C., Nonet, M.L., and Crowder, C.M. (2004). Resistance to volatile anesthetics by mutations
                        enhancing excitatory neurotransmitter release in <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Genetics <span class="emphasis"><em>168</em></span>, 831&#8211;843.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15514057&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1534/genetics.104.030502" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib34"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Holden-Dye, L., and Walker, R.J. (1990). Avermectin and avermectin derivatives are antagonists at the 4-aminobutyric acid
                        (GABA) receptor on the somatic muscle cells of <span class="emphasis"><em>Ascaris</em></span>; is this the site of anthelmintic action? Parasitology <span class="emphasis"><em>101</em></span>, 265&#8211;271.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=2175874&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib35"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Holden-Dye, L., and Walker, R.J. (2006). Actions of glutamate and ivermectin on the pharyngeal muscle of <span class="emphasis"><em>Ascaridia galli</em></span>: a comparative study with <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Int. J. Parasitol. <span class="emphasis"><em>36</em></span>, 395&#8211;402.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16442540&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.ijpara.2005.11.006" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib36"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Husson, S.J., Clynen, E., Baggerman, G., Janssen, T., and Schoofs, L. (2006). Defective processing of neuropeptide precursors
                        in <span class="emphasis"><em>Caenorhabditis elegans</em></span> lacking proprotein convertase 2 (KPC-2/<a href="http://www.wormbase.org/db/get?name=EGL-3;class=Protein" target="_blank">EGL-3</a>): mutant analysis by mass spectrometry. J. Neurochem. <span class="emphasis"><em>98</em></span>, 1999&#8211;2012.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16945111&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1111/j.1471-4159.2006.04014.x" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib37"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Jacob, T.C., and Kaplan, J.M. (2003). The <a href="http://www.wormbase.org/db/get?name=EGL-21;class=Protein" target="_blank">EGL-21</a> carboxypeptidase E facilitates acetylcholine release at <span class="emphasis"><em>Caenorhabditis elegans</em></span> neuromuscular junctions. J. Neurosci. <span class="emphasis"><em>23</em></span>, 2122&#8211;2130.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12657671&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib38"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Johnson, C.D., and Stretton, A.O. (1985). Localization of choline acetyltransferase within identified motoneurons of the nematode
                        <span class="emphasis"><em>Ascaris</em></span>. J. Neurosci. <span class="emphasis"><em>5</em></span>, 1984&#8211;1992.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=4020429&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib39"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Johnson, C.D., and Stretton, A.O. (1987). GABA-immunoreactivity in inhibitory motor neurons of the nematode <span class="emphasis"><em>Ascaris</em></span>. J. Neurosci. <span class="emphasis"><em>7</em></span>, 223&#8211;235.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=3543249&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib40"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Jones, A.K., Buckingham, S.D., and Sattelle, D.B. (2005). Chemistry-to-gene screens in <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Nat. Rev. Drug. Discov. <span class="emphasis"><em>4</em></span>, 321&#8211;330.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15803195&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1038/nrd1692" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib41"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Kagawa, H., Sugimoto, K., Matsumoto, H., Inoue, T., Imadzu, H., Takuwa, K., and Sakube, Y. (1995). Genome structure, mapping
                        and expression of the tropomyosin gene <span class="emphasis"><em>tmy-1</em></span> of <span class="emphasis"><em>Caenorhabditis elegans</em></span>. J. Mol. Biol. <span class="emphasis"><em>251</em></span>, 603&#8211;613.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7666414&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1006/jmbi.1995.0459" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib42"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Kass, I.S., Wang, C.C., Walrond, J.P., and Stretton, A.O. (1980). Avermectin B1a, a paralyzing anthelmintic that affects interneurons
                        and inhibitory motoneurons in <span class="emphasis"><em>Ascaris</em></span>. Proc. Natl. Acad. Sci. U.S.A. <span class="emphasis"><em>77</em></span>, 6211&#8211;6215.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=6255481&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1073/pnas.77.10.6211" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib43"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Kass, I.S., Larsen, D.A., Wang, C.C., and Stretton, A.O. (1982). <span class="emphasis"><em>Ascaris suum</em></span>: differential effects of avermectin B1a on the intact animal and neuromuscular strip preparations. Exp. Parasitol. <span class="emphasis"><em>54</em></span>, 166&#8211;174.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7128715&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/0014-4894(82)90123-0" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib44"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Kass, J., Jacob, T.C., Kim, P., and Kaplan, J.M. (2001). The <a href="http://www.wormbase.org/db/get?name=EGL-3;class=Protein" target="_blank">EGL-3</a> proprotein convertase regulates mechanosensory responses of <span class="emphasis"><em>Caenorhabditis elegans</em></span>. J. Neurosci. <span class="emphasis"><em>21</em></span>, 9265&#8211;9272.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11717360&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib45"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Khakh, B.S., Proctor, W.R., Dunwiddie, T.V., Labarca, C., and Lester, H.A. (1999). Allosteric control of gating and kinetics
                        at P2X(4) receptor channels. J. Neurosci. <span class="emphasis"><em>19</em></span>, 7289&#8211;7299.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=10460235&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib46"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Krause, R.M., Buisson, B., Bertrand, S., Corringer, P.J., Galzi, J.L., Changeux, J.P., and Bertrand, D. (1998). Ivermectin:
                        a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. Mol. Pharmacol. <span class="emphasis"><em>53</em></span>, 283&#8211;294.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9463487&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib47"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Kwa, M.S., Veenstra, J.G., and Roos, M.H. (1994). Benzimidazole resistance in <span class="emphasis"><em>Haemonchus contortus</em></span> is correlated with a conserved mutation at amino acid 200 in beta-tubulin isotype. Mol. Biochem. Parasitol. <span class="emphasis"><em>63</em></span>, 299&#8211;303.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7911975&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/0166-6851(94)90066-3" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib48"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Kwa, M.S., Veenstra, J.G., Van Dijk, M., and Roos, M.H. (1995). Beta-tubulin genes from the parasitic nematode <span class="emphasis"><em>Haemonchus contortus</em></span> modulate drug resistance in <span class="emphasis"><em>Caenorhabditis elegans</em></span>. J. Mol. Biol. <span class="emphasis"><em>246</em></span>, 500&#8211;510.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7877171&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1006/jmbi.1994.0102" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib49"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Lacey, E. (1990). Mode of action of benzimidazoles. Parasitol. Today <span class="emphasis"><em>6</em></span>, 112&#8211;115.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15463312&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/0169-4758(90)90227-U" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib50"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Laughton, D.L., Lunt, G.G., and Wolstenholme, A.J. (1997). Reporter gene constructs suggest that the <span class="emphasis"><em>Caenorhabditis elegans</em></span> avermectin receptor beta-subunit is expressed solely in the pharynx. J. Exp. Biol. <span class="emphasis"><em>200</em></span>, 1509&#8211;1514.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=9192499&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib51"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Lee, B.H., Clothier, M.F., Dutton, F.E., Nelson, S.J., Johnson, S.S., Thompson, D.P., Geary, T.G., Whaley, H.D., Haber, C.L.,
                        Marshall, V.P., Kornis, G.I., McNally, P.L., Ciadella, J.I., Martin, D.G., Bowman, J.W., Baker, C.A., Coscarelli, E.M., Alexander-Bowman,
                        S.J., David, J.P., Zinser, E.W., Wiley, V., Lipton, M.F., and Mauragis, M.A. (2002). Marcfortine and Paraherquamide class
                        of anthelmintics: Discovery of PNU-141962. Curr. Top. Med. Chem. <span class="emphasis"><em>2</em></span>, 779&#8211;793.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12052190&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.2174/1568026023393705" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib52"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Lewis, J.A., Wu, C.H., Berg, H., and Levine, J.H. (1980). The genetics of levamisole resistance in the nematode <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Genetics <span class="emphasis"><em>95</em></span>, 905&#8211;928.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7203008&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib53"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Li, C. (2005). The ever-expanding neuropeptide gene families in the nematode <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Parasitology <span class="emphasis"><em>131</em></span>, S109&#8211;S127.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16569285&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1017/S0031182005009376" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib54"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Martin, R.J. (1985). Gamma-Aminobutyric acid- and piperazine-activated single-channel currents from <span class="emphasis"><em>Ascaris suum</em></span> body muscle. Br. J. Pharmacol. <span class="emphasis"><em>84</em></span>, 445&#8211;461.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=2579701&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib55"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Martin, R.J., Verma, S., Levandoski, M., Clark, C.L., Qian, H., Stewart, M., and Robertson, A.P. (2005). Drug resistance and
                        neurotransmitter receptors of nematodes: recent studies on the mode of action of levamisole. Parasitology <span class="emphasis"><em>131</em></span>, S71&#8211;S84.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16569294&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1017/S0031182005008668" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib56"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Maryon, E.B., Coronado, R., and Anderson, P. (1996). <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-68;class=Gene" target="_blank">unc-68</a></em></span> encodes a ryanodine receptor involved in regulating <span class="emphasis"><em>C. elegans</em></span> body-wall muscle contraction. J. Cell Biol. <span class="emphasis"><em>134</em></span>, 885&#8211;893.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8769414&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1083/jcb.134.4.885" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib57"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Miller K.G., Alfonso, A., Nguyen, M., Crowell, J.A., Johnson, C.D., and Rand, J.B. (1996). A genetic selection for <span class="emphasis"><em>Caenorhabditis elegans</em></span> synaptic transmission mutants. Proc. Natl. Acad. Sci. U.S.A. <span class="emphasis"><em>93</em></span>, 12593&#8211;12598.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8901627&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1073/pnas.93.22.12593" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib58"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Mitreva, M., Blaxter, M.L., Bird, D.M., and McCarter, J.P. (2005). Comparative genomics of nematodes. Trends Genet. <span class="emphasis"><em>21</em></span>, 573&#8211;581.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16099532&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.tig.2005.08.003" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib59"></a><p class="bibliomixed">
                     		<span class="bibliomisc">McVeigh, P., Leech, S., Mair, G.R., Marks, N.J., Geary, T.G., and Maule A.G. (2005). Analysis of FMRFamide-like peptide (FLP)
                        diversity in phylum Nematoda. Int. J. Parasitol. <span class="emphasis"><em>35</em></span>, 1043&#8211;1060.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16076468&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.ijpara.2005.05.010" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib60"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Moerman, D.G., Benian, G.M., Barstead, R.J., Schriefer, L.A., and Waterston, R.H. (1988). Identification and intracellular
                        localization of the <span class="emphasis"><em><a href="http://www.wormbase.org/db/get?name=unc-22;class=Gene" target="_blank">unc-22</a></em></span> gene product of <span class="emphasis"><em>Caenorhabditis elegans.</em></span> Genes Dev. <span class="emphasis"><em>2</em></span>, 93&#8211;105.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=2833427&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1101/gad.2.1.93" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib61"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Nguyen, M., Alfonso, A., Johnson, C.D., and Rand, J.B. (1995). <span class="emphasis"><em>Caenorhabditis elegans</em></span> mutants resistant to inhibitors of acetylcholinesterase. Genetics <span class="emphasis"><em>140</em></span>, 527&#8211;535.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=7498734&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib62"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Pemberton, D.J., Franks, C.J., Walker, R.J., and Holden-Dye, L. (2001). Characterization of glutamate-gated chloride channels
                        in the pharynx of wild-type and mutant <span class="emphasis"><em>Caenorhabditis elegans</em></span> delineates the role of the subunit GluCl-alpha2 in the function of the native receptor. Mol. Pharmacol. <span class="emphasis"><em>59</em></span>, 1037&#8211;1043.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11306685&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib63"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Portillo, V., Jagannathan, S., and Wolstenholme, A.J. (2003). Distribution of glutamate-gated chloride channel subunits in
                        the parasitic nematode <span class="emphasis"><em>Haemonchus contortus</em></span>. J. Comp. Neurol. <span class="emphasis"><em>462</em></span>, 213&#8211;222.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12794744&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1002/cne.10735" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib64"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Qian, H., Martin, R.J., and Robertson, A.P. (2006). Pharmacology of N-, L-, and B-subtypes of nematode nAChR resolved at the
                        single-channel level in <span class="emphasis"><em>Ascaris suum</em></span>. FASEB J. <span class="emphasis"><em>20</em></span>, 2606&#8211;2608.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17056760&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1096/fj.06-6264fje" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib65"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Rand, J.B. (January 2007). Acetylcholine. WormBook, ed. The <span class="emphasis"><em>C. elegans</em></span> Research Community, WormBook, doi/10.1895/wormbook.1.131.1, <a href="http://www.wormbook.org" target="_blank">http://www.wormbook.org</a>.</span>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib66"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Rand, J.B., and Johnson, C.D. (1995). Genetic pharmacology: interactions between drugs and gene products in <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Methods Cell Biol. <span class="emphasis"><em>48</em></span>, 187&#8211;204.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=8531725&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib67"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Robertson, A.P., Clark, C.L., Burns, T.A., Thompson, D.P., Geary, T.G., Trailovic, S.M., and Martin, R.J. (2002). Paraherquamide
                        and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in <span class="emphasis"><em>Ascaris</em></span> muscle. J. Pharmacol. Exp. Ther. <span class="emphasis"><em>302</em></span>, 853&#8211;860.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12183640&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1124/jpet.102.034272" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib68"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Robertson, B. (1989). Actions of anaesthetics and avermectin on GABAA chloride channels in mammalian dorsal root ganglion
                        neurones. Br. J. Pharmacol. <span class="emphasis"><em>98</em></span>, 167&#8211;176.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=2478243&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib69"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Saeger, B., Schmitt-Wrede, H.P., Dehnhardt, M., Benten, W.P., Krucken, J., Harder, A., von Samson-Himmelstjerna, G., Wiegand,
                        H., and Wunderlich, F. (2001). Latrophilin-like receptor from the parasitic nematode <span class="emphasis"><em>Haemonchus contortus</em></span> as target for the anthelmintic depsipeptide PF1022A. FASEB J. <span class="emphasis"><em>15</em></span>, 1332&#8211;1334.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11344131&amp;dopt=Abstract" target="_blank">Abstract</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib70"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Salkoff, L., Butler, A., Ferreira, G., Santi, C., and Wei A. (2006). High-conductance potassium channels of the SLO family.
                        Nat Rev Neurosci. <span class="emphasis"><em>7</em></span>, 921&#8211;931.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=17115074&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1038/nrn1992" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib71"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Schaeffer, J.M., Blizzard, T.A., Ondeyka, J., Goegelman, R., Sinclair, P.J., and Mrozik, H. (1992). [<sup>3</sup>H]-Paraherquamide binding to <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Studies on a potent new anthelmintic agent. Biochem. Pharmacol. <span class="emphasis"><em>43</em></span>, 679&#8211;684.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=1540222&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/0006-2952(92)90230-G" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib72"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Sieburth, D., Ch'ng, Q., Dybbs, M., Tavazoie, M., Kennedy, S., Wang, D., Dupuy, D., Rual, J.F., Hill, D.E., Vidal, M., Ruvkun,
                        G., and Kaplan, J.M. (2005). Systematic analysis of genes required for synapse structure and function. Nature <span class="emphasis"><em>436</em></span>, 510&#8211;517.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=16049479&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1038/nature03809" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib73"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Shan, Q., Haddrill, J.L., and Lynch, J.W. (2001). Ivermectin, an unconventional agonist of the glycine receptor chloride channel.
                        J. Biol. Chem. <span class="emphasis"><em>276</em></span>, 12556&#8211;12564.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11278873&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1074/jbc.M011264200" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib74"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Towers, P.R., Edwards, B., Richmond, J.E., and Sattelle, D.B. (2005). The <span class="emphasis"><em>Caenorhabditis elegans <a href="http://www.wormbase.org/db/get?name=lev-8;class=Gene" target="_blank">lev-8</a></em></span> gene encodes a novel type of nicotinic acetylcholine receptor alpha subunit. J. Neurochem. <span class="emphasis"><em>93</em></span>, 1&#8211;9.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15773900&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1111/j.1471-4159.2004.02951.x" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib75"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Wang, Z.W., Saifee, O., Nonet M.L., and Salkoff L. (2001). <a href="http://www.wormbase.org/db/get?name=SLO-1;class=Protein" target="_blank">SLO-1</a> potassium channels control quantal content of neurotransmitter release at the <span class="emphasis"><em>C. elegans</em></span> neuromuscular junction. Neuron <span class="emphasis"><em>32</em></span>, 867&#8211;881.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11738032&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/S0896-6273(01)00522-0" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib76"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Willson, J., Amliwala, K., Harder, A., Holden-Dye, L., and Walker, R.J. (2003). The effect of the anthelmintic emodepside
                        at the neuromuscular junction of the parasitic nematode <span class="emphasis"><em>Ascaris suum</em></span>. Parasitology <span class="emphasis"><em>126</em></span>, 79&#8211;86.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12613766&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1017/S0031182002002639" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib77"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Willson, J., Amliwala, K., Davis, A., Cook, A., Cuttle, M.F., Kriek, N., Hopper, N.A., O'Connor, V., Harder, A., Walker, R.J.,
                        and Holden-Dye, L. (2004). Latrotoxin receptor signaling engages the UNC-13-dependent vesicle-priming pathway in <span class="emphasis"><em>C. elegans</em></span>. Curr. Biol. <span class="emphasis"><em>14</em></span>, 1374&#8211;1379.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15296755&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.cub.2004.07.056" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib78"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Wolstenholme, A.J., Fairweather, I., Prichard, R., von Samson-Himmelstjerna, G., and Sangster, N.C. (2004). Drug resistance
                        in veterinary helminths. Trends Parasitol. <span class="emphasis"><em>20</em></span>, 469&#8211;476.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=15363440&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/j.pt.2004.07.010" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib79"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Yates, D.M., Portillo, V., and Wolstenholme, A.J. (2003). The avermectin receptors of <span class="emphasis"><em>Haemonchus contortus</em></span> and <span class="emphasis"><em>Caenorhabditis elegans</em></span>. Int. J. Parasitol. <span class="emphasis"><em>33</em></span>, 1183&#8211;1193.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=13678634&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1016/S0020-7519(03)00172-3" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib80"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Zheng, Y., Hirschberg, B., Yuan, J., Wang, A.P., Hunt, D.C., Ludmerer, S.W., Schmatz, D.M., and Cully, D.F. (2002). Identification
                        of two novel <span class="emphasis"><em>Drosophila melanogaster</em></span> histamine-gated chloride channel subunits expressed in the eye. J. Biol. Chem. <span class="emphasis"><em>277</em></span>, 2000&#8211;2005.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=11714703&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1074/jbc.M107635200" target="_blank">Article</a>
                     	
                  </p>
               </div>
               <div class="bibliomixed"><a name="bib81"></a><p class="bibliomixed">
                     		<span class="bibliomisc">Zinser, E.W., Wolfe, M.L., Alexander-Bowman, S.J., Thomas, E.M., Davis, J.P., Groppi, V.E., Lee, B.H., Thompson, D.P., and
                        Geary, T.G. (2002). Anthelmintic paraherquamides are cholinergic antagonists in gastrointestinal nematodes and mammals. J.
                        Vet. Pharmacol. Therap. <span class="emphasis"><em>25</em></span>, 241&#8211;250.</span>
                     <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;list_uids=12213111&amp;dopt=Abstract" target="_blank">Abstract</a>
                     <a href="http://dx.doi.org/10.1046/j.1365-2885.2002.00423.x" target="_blank">Article</a>
                     	
                  </p>
               </div>
            </div>
            <p></p>
         </div>
         <div class="footnotes"><br><hr width="100" align="left">
            <div class="footnote">
               <p><sup><a name="ftn.d0e8" href="#d0e8">*</a></sup>Edited by Villu Maricq and Steven L. McIntire. Submitted November 15th., 2006. Last revised May 22, 2007. Published November
                  02, 2007. This chapter should be cited as: Holden-Dye, L. and Walker, R.J. Anthelmintic drugs (November 02, 2007), <span class="emphasis"><em>WormBook</em></span>, ed. The <span class="emphasis"><em>C. elegans</em></span> Research Community, WormBook, doi/10.1895/wormbook.1.143.1, <a href="http://www.wormbook.org" target="_top">http://www.wormbook.org</a>.
               </p>
               <p><span class="bold"><strong>Copyright:</strong></span> &copy; 2007 Lindy Holden-Dye and Robert J. Walker. This is an open-access article distributed under the terms of the Creative
                  Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original
                  author and source are credited.
               </p>
            </div>
            <div class="footnote">
               <p><sup><a name="ftn.d0e30" href="#d0e30">&sect;</a></sup>To whom correspondence should be addressed. Tel: 44 (0) 23 8059 4295; Fax: 44 (0) 23 80594459. E-mail: <a href="mailto:lmhd@soton.ac.uk" target="_top">lmhd@soton.ac.uk</a></p>
			   <p><img src="somerights20.gif" alt="Creative Commons License" align="middle" border="0"> All WormBook content, except where otherwise noted, is licensed under a <a href="http://creativecommons.org/licenses/by/2.5/" title="Creative Commons Attribution License" target="_blank">Creative Commons Attribution License</a>.</p>
            </div>
         </div>
      </div>
   <!--#include virtual="/ssi/footer.html" --></body>
</html>
